Constanze Schmidt - Publications

Affiliations: 
2008- Georg-August-Universität Göttingen, Göttingen, Niedersachsen, Germany 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Wiedmann F, Kraft M, Kallenberger S, Büscher A, Paasche A, Blochberger PL, Seeger T, Jávorszky N, Warnecke G, Arif R, Kremer J, Karck M, Frey N, Schmidt C. MicroRNAs Regulate TASK-1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation. Journal of the American Heart Association. 11: e023472. PMID 35301863 DOI: 10.1161/JAHA.121.023472  0.686
2021 Wiedmann F, Beyersdorf C, Zhou XB, Kraft M, Paasche A, Jávorszky N, Rinné S, Sutanto H, Büscher A, Foerster KI, Blank A, El-Battrawy I, Li X, Lang S, Tochtermann U, ... ... Schmidt C, et al. Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy. Cardiovascular Research. PMID 34028533 DOI: 10.1093/cvr/cvab177  0.706
2020 Schmidt C, Benda S, Kraft P, Wiedmann F, Pleger S, Büscher A, Thomas D, Wachter R, Schmid C, Eils R, Katus HA, Kallenberger SM. Prospective multicentric validation of a novel prediction model for paroxysmal atrial fibrillation. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. PMID 33211156 DOI: 10.1007/s00392-020-01773-z  0.694
2020 Schmidt C, Kallenberger SM. Ageing is associated with increased variability of cellular reprogramming and wound healing. Cardiovascular Research. 116: e171-e174. PMID 33096562 DOI: 10.1093/cvr/cvaa294  0.641
2019 Kallenberger SM, Schmidt C. Forecasting the development of acute kidney injury using a recurrent neural network. Cardiovascular Research. PMID 31697360 DOI: 10.1093/cvr/cvz279  0.641
2019 Schmidt C, Wiedmann F, Beyersdorf C, Zhao Z, El-Battrawy I, Kraft M, Lang S, Szabo G, Karck M, Zhou X, Borggrefe M, Thomas D, Haefeli WE, Decher N, Katus H. 1206Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation European Heart Journal. 40. DOI: 10.1093/eurheartj/ehz748.0036  0.31
2017 Schmidt C, Wiedmann F, Kallenberger SM, Ratte A, Schulte JS, Scholz B, Müller FU, Voigt N, Zafeiriou MP, Ehrlich JR, Tochtermann U, Veres G, Ruhparwar A, Karck M, Katus HA, et al. Stretch-activated two-pore-domain (K2P) potassium channels in the heart: Focus on atrial fibrillation and heart failure. Progress in Biophysics and Molecular Biology. PMID 28526353 DOI: 10.1016/j.pbiomolbio.2017.05.004  0.707
2017 Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, et al. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. European Heart Journal. PMID 28057773 DOI: 10.1093/Eurheartj/Ehw559  0.713
2016 Kallenberger SM, Schmid C, Wiedmann F, Mereles D, Katus HA, Thomas D, Schmidt C. A Simple, Non-Invasive Score to Predict Paroxysmal Atrial Fibrillation. Plos One. 11: e0163621. PMID 27680490 DOI: 10.1371/journal.pone.0163621  0.688
2016 Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, et al. Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation". Circulation. 133: e440-1. PMID 26976923 DOI: 10.1161/CIRCULATIONAHA.115.020662  0.696
2015 Glasscock E, Voigt N, McCauley MD, Sun Q, Li N, Chiang DY, Zhou XB, Molina CE, Thomas D, Schmidt C, Skapura DG, Noebels JL, Dobrev D, Wehrens XH. Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation. Basic Research in Cardiology. 110: 505. PMID 26162324 DOI: 10.1007/S00395-015-0505-6  0.304
2015 Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabó G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, et al. Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients with Chronic Atrial Fibrillation. Circulation. PMID 25951834 DOI: 10.1161/CIRCULATIONAHA.114.012657  0.704
2014 Kallenberger SM, Schmidt C, Dechent P, Forster C, von Steinbüchel N, Wüstenberg T, Strasburger H. Separating fusion from rivalry. Plos One. 9: e103037. PMID 25054904 DOI: 10.1371/Journal.Pone.0103037  0.664
2014 Schmidt C, Wiedmann F, Langer C, Tristram F, Anand P, Wenzel W, Lugenbiel P, Schweizer PA, Katus HA, Thomas D. Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 11: 1798-805. PMID 24952150 DOI: 10.1016/j.hrthm.2014.06.020  0.307
2014 Schmidt C, Wiedmann F, Tristram F, Anand P, Wenzel W, Lugenbiel P, Schweizer PA, Katus HA, Thomas D. Cardiac expression and atrial fibrillation-associated remodeling of Kâ‚‚p2.1 (TREK-1) K⁺ channels in a porcine model. Life Sciences. 97: 107-15. PMID 24345461 DOI: 10.1016/j.lfs.2013.12.006  0.303
2010 Kallenberger S, Schmidt C, Wustenberg T, Strasburger H. Visual Fusion and Binocular Rivalry in Cortical Visual Areas Journal of Vision. 10: 360-360. DOI: 10.1167/10.7.360  0.695
2003 Carmesin HO, Kallenberger S, Schmidt C. [Shutter-glasses haploscope with eye-tracking control for fusion therapy]. Klinische MonatsbläTter FüR Augenheilkunde. 220: 629-33. PMID 14533062 DOI: 10.1055/s-2003-42810  0.648
Show low-probability matches.